Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial.

Neoptolemos JP, Stocken DD, Bassi C, Ghaneh P, Cunningham D, Goldstein D, Padbury R, Moore MJ, Gallinger S, Mariette C, Wente MN, Izbicki JR, Friess H, Lerch MM, Dervenis C, Oláh A, Butturini G, Doi R, Lind PA, Smith D, Valle JW, Palmer DH, Buckels JA, Thompson J, McKay CJ, Rawcliffe CL, Büchler MW; European Study Group for Pancreatic Cancer..

JAMA. 2010 Sep 8;304(10):1073-81. doi: 10.1001/jama.2010.1275.

PMID:
20823433
2.

Neoadjuvant and adjuvant strategies for pancreatic cancer.

Ghaneh P, Smith R, Tudor-Smith C, Raraty M, Neoptolemos JP.

Eur J Surg Oncol. 2008 Mar;34(3):297-305. Epub 2007 Oct 22. Review.

PMID:
17936564
3.
4.

Adjuvant therapy in pancreatic cancer: historical and current perspectives.

Neoptolemos JP, Cunningham D, Friess H, Bassi C, Stocken DD, Tait DM, Dunn JA, Dervenis C, Lacaine F, Hickey H, Raraty MG, Ghaneh P, Büchler MW.

Ann Oncol. 2003 May;14(5):675-92. Review.

PMID:
12702520
5.

Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer.

Ur Rehman SS, Lim K, Wang-Gillam A.

Expert Rev Anticancer Ther. 2016 May;16(5):485-92. doi: 10.1080/14737140.2016.1174581. Epub 2016 Apr 22. Review.

PMID:
27043737
6.

The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy.

Passero FC Jr, Grapsa D, Syrigos KN, Saif MW.

Expert Rev Anticancer Ther. 2016 Jul;16(7):697-703. doi: 10.1080/14737140.2016.1192471. Epub 2016 Jun 3. Review.

PMID:
27219482
7.

Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma.

Lamb YN, Scott LJ.

Drugs. 2017 May;77(7):785-792. doi: 10.1007/s40265-017-0741-1. Review.

PMID:
28401446
8.

Chemotherapy for advanced pancreatic cancer: it may no longer be ignored.

Cascinu S, Graziano F, Catalano G.

Ann Oncol. 1999 Jan;10(1):105-9. Review.

PMID:
10076729
9.

Pancreatic cancer--is the wall crumbling?

Chua YJ, Zalcberg JR.

Ann Oncol. 2008 Jul;19(7):1224-30. doi: 10.1093/annonc/mdn063. Epub 2008 Apr 1. Review.

PMID:
18381371
10.

ESPAC-1 trial progress report: the European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer.

Neoptolemos JP, Kerr DJ, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Laçaine F, Friess H, Büchler M.

Digestion. 1997;58(6):570-7. Review.

PMID:
9438604
12.

[Chemotherapy for pancreatic cancer].

Kim YT.

Korean J Gastroenterol. 2008 Feb;51(2):111-8. Review. Korean.

13.

Pancreatic cancer.

Kamisawa T, Wood LD, Itoi T, Takaori K.

Lancet. 2016 Jul 2;388(10039):73-85. doi: 10.1016/S0140-6736(16)00141-0. Epub 2016 Jan 30. Review.

PMID:
26830752
14.

Monoclonal antibodies and other targeted therapies for pancreatic cancer.

Cinar P, Tempero MA.

Cancer J. 2012 Nov-Dec;18(6):653-64. doi: 10.1097/PPO.0b013e3182758985. Review.

PMID:
23187854
15.

Second-line treatment in advanced pancreatic cancer: a comprehensive analysis of published clinical trials.

Rahma OE, Duffy A, Liewehr DJ, Steinberg SM, Greten TF.

Ann Oncol. 2013 Aug;24(8):1972-9. doi: 10.1093/annonc/mdt166. Epub 2013 May 12. Review.

16.

[Arterial infusion chemotherapy for patients with advanced pancreatic cancer].

Suga H, Okabe Y, Ono N, Saito F, Nagaoka S, Tsuruta O, Toyonaga A, Sata M.

Gan To Kagaku Ryoho. 2006 Sep;33(9):1226-30. Review. Japanese.

PMID:
16969015
17.

Adjuvant and Neoadjuvant Therapy for Pancreatic Cancer.

Li D, O'Reilly EM.

Surg Oncol Clin N Am. 2016 Apr;25(2):311-26. doi: 10.1016/j.soc.2015.11.010. Epub 2016 Feb 17. Review.

PMID:
27013366
18.

Intravenous and intra-arterial chemotherapeutic possibilities in biliopancreatic cancer.

van Groeningen CJ.

Ann Oncol. 1999;10 Suppl 4:305-7. Review.

PMID:
10436846
19.

Adjuvant therapy in pancreatic cancer.

Ghaneh P, Slavin J, Sutton R, Hartley M, Neoptolemos JP.

World J Gastroenterol. 2001 Aug;7(4):482-9. Review.

20.

Adjuvant and neoadjuvant systemic therapy for pancreas adenocarcinoma.

Li D, O'Reilly EM.

Semin Oncol. 2015 Feb;42(1):134-43. doi: 10.1053/j.seminoncol.2014.12.012. Epub 2014 Dec 9. Review.

Supplemental Content

Support Center